How could an open access DNA-encoded library benefit your research?

OpenDEL®3.0 is a self-service DNA-encoded library (DEL) kit product to enable users to explore DEL selection campaigns without requiring to reveal their target identity. The users are able to perform affinity selections according to the selection manual and HitGen team provides technical support on DEL selections, high-throughput sequencing, and data analysis. This webinar will provide an overview of HitGen’s DEL platform and will highlight the workflow, key features, and customer experiences of OpenDEL®3.0 kits. Key Features of OpenDEL®3.0 kits:

  1. Transparency: all DEL information (reagents and codons) is open to the users; the selection manual and key materials for selections are provided along with OpenDEL®3.0 product.
  2. Drug-likeness: three-cycle DELs containing 90% molecules give MW <550 daltons.
  3. Reliability: robust chemistry and strict library QC.
  4. No downstream obligation: no compound disclosure fee and license fee for hits discovered from OpenDEL®3.0.
watch now
Watch the webinar on demand
Guansai Liu

Guansai Liu

Executive Director of Chemistry at Discovery Chemistry Unit, HitGen Inc.

Dr. Guansai Liu is Executive Director of Chemistry at Discovery Chemistry Unit, HitGen Inc. Liu performed his doctoral research on total synthesis of structurally-complex natural products under Professor Zhujun Yao’s guidance. After earned his Ph.D degree in organic chemistry from the University of Science and Technology of China in 2010, he then worked at Georgia State University as a post-doctoral research fellow, working on aminohydroxylations of olefins with non-precious metal catalysis. In November of 2013, Liu joined HitGen Inc. focusing on building and leading DNA-encoded chemical library platforms for early small-molecule drug discovery and optimization. He has published over 26 articles and papers in leading peer-reviewed journals such as J. Am. Soc. Chem., Org. Lett., etc.

Arsalan Arif

Arsalan Arif

Founder & publisher, endpoints news

Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.